common

Hepion Pharmaceuticals Inc

hand

10% of the float is in institutional index funds hands and that is shite.

In the last 2 years many weak hands have lost money selling for desperation..We are all  Screwed since we were part of a well organized fraudulent plan.

Won’t give them another dollar from my hand earned money…

Where you  perhaps you planned to spend what time you have might , if you are caught , just slip out of your hands !

short

The naked shorters are starting to feel the cactus being slowly shoved up their asses.

$HEPA $CVNA Shorts in big trouble in both these tickers

$HEPA shorties better cover!! 🤦🏼‍♂️🤦🏼‍♂️🤡🤡😂😂😂

$HEPA it seems like shorts got caught naked.

Sit there bitching and complaining about shorts.

Shorts are trapped and face more issues as share prices continues rising.

shit

$HEPA Can someone please explain to me why longs keep torturing themselves day after day by holding on to this crap?

$HEPA MMs using six decimals is effing bullshit!

$KERN very nice PT 10+ love $xpon more tomorrow and $CLPS $HEPA $AMC all in for tomorrow

also $celu with a PT of 15 and $hepa on good news..

I particularly like the line &quot;All common stock issued by the Company to-date is included in total shares issued and outstanding.&quot;  No one is saying the shares weren&#39;t issued.

news

$HEPA the consolidation over last weeks is bullish … one day it will explode above 0,88$ or maybe with Gap Up after news … the day is near , Szenario destroyed &lt; 0,66$

The news for $NVS and $PLRX closing their relationship in NASh is good for $HEPA, in my opinion.

prepare for the positive news they know is coming.

The good news is that this stock can be manipulated both ways.

$HEPA 20 something percent haircut over a great news.

$HEPA @BioTuesdays good to see bioTuesday has so much great HEPA news to put out that they have to release some of it on Wednesday ! 🤣

drug

The only thing im sure about with this company is that its drug has great potential

This makes Rencofilstat a promising candidate for the treatment of a variety of diseases, including thromboembolic disorders, sepsis, and cancer.

if this is truly a 4B, 5B or more mkt cap drug it’ll ultimately end up with a SP in the hundreds of dollars (assuming RS goes through) and everyone will be happy in the long run.

Despite everything, the fact remains that absolutely nobody has come up with anything substantially bad to report about this amazing drug.

For any investor, being able to buy the company below cash value while getting the wonder drug, Rencofilstat, for free is a VERY attractive investment proposition.

That drug has been proven to be safe to be used in tandem with any other known drugs.

$HEPA this drug is game changer in hepatology!

2023 is going to be highlighted with a continuous cascade of amazingly positive PR’s confirming the fact (already documented in 300+ early clinical studies), that Rencofilstat is truly a Wonder Drug to be celebrated, with an extraordinarily large TAM.

My recommendation is to trust the science and say Buy! Buy!

$HEPA Big nice buy orders being executed. @.

$HEPA this is an extreme buy and HOLD- no one should be selling a share

ReShape Lifesciences Inc.

$RSLS Straight fuckery with these shorts assholes

$RSLS shorts and naked shorts taking the piss again

$JFBR these greedy shorts deserve to get squeezed.

$RSLS oh boy $22 in next 5 minutes, shorts in trouble

They are bad anyway

 $NCMI $ANY and $NRBO lots of
Volume here 

 $RSLS sad what the shorts are
Doing

hold

NEVER EVER HOLD A RUNNER OVER THE WEEKEND, HECK NEVER EVER HOLD A RUNNER OVERNIGHT NOT UNLESS YOU HAVE A CRYSTAL BALL AND I KNOW NO NONE DOES.

$RSLS Don’t hold this garbage I promise you you will regret it.

reversal

$RSLS retest of highs possible

$LUV southwest is dead.. Rip

$COSM holy ross rip my ass 
 
$BBBY $RSLS $KALA

company

$RSLS what ever happened to that kid who filed sec report after he bought 10% of the company over $5 Lol lmao
 wow the dump in this name has been nasty ….

Buyer beware, it’s not a good company, stop pretending like it is.

I realize that management of this company never think about shareholders as most of biotech companies do.

$RSLS The amount of time and effort you’re putting in bashing this company is highly suspicious.

It is still a money losing company that need to issue massive amounts of shares to keep paying incompetent management’s salaries.

$RSLS everyone do research on this company before you invest a dime it’s a scam be careful

COMPANY IS NOT REQUESTING TO WITHDRAW THE ABOVE REGISTRATION STATEMENT, MERELY THE TWO FORM RWs 
THAT WERE INCORRECTLY TAGGED.!!!

To be clear, the Company is not requesting to withdraw the above registration statement, merely the two Form RWs that were incorrectly tagged.

$RSLS they do when you are dealing with garbage companies! 😂💩💩🩸

- PT 80$ (whoever)
- 6 months low for no reason! - Q4 best in company history (expected)

$RSLS $GENE $PT $MINM $APRN 

The Good Old Days are Back 🤑 
Going to Be a Very Lucrative Life Changing Year

$RSLS $9.52 Alert to $20+ pt ! 🔥🔥🔥🔥🔥🔥

$HSCS $RSLS $GENE $GPCR      
 
     COMMON SENSE INVESTING!

profit

.glad I took my $49.80 profit when i did!!! !

They have hit the jackpot with their prediction on $BGXX and made a STAGGERING 17% PROFIT with ease.

$MGAM 
$RSLS
$LUCY
$TENX
$HILS thank for all the profits this week can&#39;t wait for next week buying my wife her stilettos for valentines day

$RSLS bringing some of my profits over to $BLPG 💯💯💯💯

BULLISH on volatility and trading locking in profits frequently.

Now i am calling $tcbp for a nice profit from these levels.

Now i am calling $GMVD for a nice profit from these levels.

bull

but I’m a bull and giving us opportunities to add n accumulate on the low volume dips ..

$RSLS nice bull pennant breakout, could test the days high soon

$RSLS 353k float let’s run it bulls 🚀🚀

$RSLS 27% up 5% down good job you fake punk ass bulls

volume

$INVO volume pick up $TENX and $RSLS ! !🚀🚀🚀🚀😆

$rsls nice pop

 $KALA 500,000 volume not bad

 $NVOS pulling back a bit 

 $MYO decent morning here

🚨Relative Volume Increase🚨 Part 1

$RSLS $PALT $LMFA $IFBD $SFIG 

Stay tuned for more ideas!

$RFL on the move  looknig great and strong a lot of room to run here   
golden cross is in 50ma vs 200ma = LONG (For the first time since October 2021)  
we need to breakout  2.41 and 2.51 for huge RUNUP   
low float volume is the key   
it was 66$ !!!

$RSLS nice formation, great, volume, strong rsi, and let’s not forget patent was approved

Cassava Sciences Inc

action

The day to day price action of this limp dick is more painful to watch than slugs breeding.

$SAVA , this daily one way action is depressing.

Zero confidence in management based on both recent actions and historical issues with the FDA. 2.

$SAVA We may get frustrated with volatility, manipulation, and irregular daily price action

price

This is sickening that these crooks can manipulate the price like this. !!!

He invites shorts to destroy stock price.. pathetic!

Some had to drop in price a little first!

new employee mr. cook must be pissed as this is lower price than the shares he got it for.

All.u did was dilute the pps 
..and release to prs to kill the stock price and momentum  
 You did so well..you fxuking scumbag.

I hate the stock price runup leading to an announcement.

data

- 
$AVXL in comparison, boring as hell - whenever Missling talks people fall asleep and holding back data and further readouts without any logical explanation are red flags -

$SAVA 
Pyggie here was bullish a few days ago, folded like a pussy because he can’t read data, and now spews FUD, like a spoiled child, because he’s worried he may have paper-handed a monster.

but offer only the “opinion” that there was “possible data manipulation.”

$SAVA longtime biotech investor and my honest experience when a CEO promises good data and there is a long waiting period = not good.

Sentiment matters in this game, and unfortunately, this company has been drug through the mud for so long that good data might just get overlooked.

$SAVA The ironic and sad thing is that this ticker has been abused and manipulated so badly that even if it triples on upcoming data release it still won&#39;t come close to ATH achieved on much less evidence of safety and efficacy.

The CEO belongs in jail with all this pump and dump stock manipulation and data manipulation

just annoying we all get so worked up and insulting when we, the retail investor, can neither move Remi to release data early or in truth, move the SP by buying or selling a few hundred shares.

$SAVA dumb management causing longs to lose confidence, you dont change the date of data release every few weeks, just give a date when you are certain and stick with that, its that simple

BIIB with a 27% chance of no decline - so bad, how can they even publish data like that.

patient

however, if you are a family member of Alz patient think about how fatiguing emotionally and financially it is to change diapers, have your name forgotten, or even have to take a license away from an otherwise healthy person.

but your day will come when you will pay back way more than the damage you have caused and the lives you have threatened from being treated for a debilitating disease.

$ALZN $ATHA $ORMP $SAVA $SPRC yes then go back to your scam board clown no need to trap others in this scam .. we know what value SAVA brings to their AD patients

Lecanemab approved - IV  infusion..increased infection risk, inconvenient for patients with MD&#39;s fully aware 
of side effects: brain swelling and bleeding. 2.

Eventually, the  
AD patient is unable to perform daily functions.

But the monoclonal antibody treatment also carries risks of brain swelling and bleeding.

$BIIB - lied and tried to push their bad drug Aduhelm on unsuspecting patients (one of which is a family member of mine).

3 deaths in 1900 trial patients.. how many deaths is our FDA going to inflict on millions of folks who are supposed to take this death drugs that also happen to have near-zero efficacy?? SMH

Avxl, not good they didn&#39;t have an agreement in place “plan for approval“ before they started the test fase 2b 500 patients.

$SAVA It&#39;s not only CRUEL for anyone to be prescribing any of these MABs for AD patients, it&#39;s impractical for both patients and the healthcare system in general.

application

$SAVA Words  to  to  ignorant,  never  hype  a  employee  from  fda,  shady  shiat! 🤡🤡🤡😂😂😂

It doesn&#39;t matter if drugs for terminal illnesses, have been approved after 6 months, because there is endless manipulation here, and this waiting game is based on either FDA approval or denial based on corruption at the agency?

This is such crap with the FDA my Father died a year ago from it

$BIIB $SAVA You would need uncommon patience to not be crazy mad at the system for this shenanigan approval process and decision from the FDA.

Idiots with no respect for integrity continues  to run 
wild within the FDA.

$SAVA once again we got fu*ked by the evil BIIB + FDA.

$SAVA THIS is how corrupt our FDA and state medical boards are.

$BIIB $SAVA  
I tell ya why - FDA is corrupt deep in its root, period!

$SAVA Love this, sold at 62 a few weeks ago, bought back rince and repeat.. $aehl very bullish uptrend Marketwatch analyst BUY with PT of 16+ and love $GREE

$ESTA PT here is $100 and recent good news, Also like $SAVA $TMBR

This is quite common and nothing negative for Cassava Sciences.

business-result

But the company actually has never seen before wonderful results.

And, make no mistake, the result are impressive.

It is the best results that have been seen in AD.

This could be huge in eliminating artificial FUD against the top-line results.

$SAVA Market is moving higher as SAVA is expecting data results.

Anavex is late like the sun comes up and still produces great results.

MOST IMPORTANTLY, THE RESULTS MUST HAVE BEEN GOOD AND PROMISING at each snapshot that leads Remi to use the word &quot;Thrilled&quot; in Dec 6 PR.

Data tells me no safety issues, with a possible large therapeutic window.

Then they dropped the “good” totally “not disappointing” data that Remi was so “Thrilled” about.

This will go beyond parabolic on good data … literally no shares out there unless they offer new ones … $MDGL $VKTX $SLS $SAVA

SAVA data gets analyzed by multiple different labs and shows its cognition improvement in mild AD cases, safe and well-tolerated

$SAVA I love not being able to hold $28 off data that will keep it pinned here until 2024.

but the data to date would predict continued efficacy that will be nigh on impossible to ignore.

$SAVA Institutional buying says data is good!! !

I’ll keep buying until data comes out…

Excited for the next data unveiling….bring it on!

$SAVA “Treatment also eased depression and dementia-related behaviors in patients, two exploratory trial goals, and simufilam was found to be safe and well tolerated.”

This will bring in billions of revenue and it will make the life quality longer for AD patients.

This sub-set of patients improved -4.96 mean points on ADAS-Cog from baseline to month 12.

CURING LEUKEMIA isn&#39;t a fly by night thing with Gamma T Cells and they already have ONE COMPLETE RESPONSE curing someone in Stage 4 nonresponsive to other treatments!

$SAVA this is going to be game changer and first drug to give some relief to AD patients … and will make $BIIB poison AD pills an obsolete

The high number of the patients that went into CMS (which is 80% complete) is reassuring.

but reverses cognitive decline and improves quality of life for the patient AND the FAMILY!

but mostly new hope for all the families and patients with AZ.

Testing still continues, so in my way of thinking the real-world results in patients must be nothing short of excellent.

HEPA

Hepion Pharmaceuticals Inc

-16.85%

$0.86 - $0.72

Jan, 11, 2023

Jan, 11, 2023

RSLS

ReShape Lifesciences Inc.

-48.86%

$5.91 - $3.02

Feb, 12, 2023

Feb, 3, 2023

SAVA

Cassava Sciences Inc

-13.96%

$29.88 - $25.71

Jan, 11, 2023

Dec, 12, 2022

HEPA

Hepion Pharmaceuticals Inc

-16.85%

$0.86 - $0.72

Jan, 11, 2023

Jan, 11, 2023

RSLS

ReShape Lifesciences Inc.

-48.86%

$5.91 - $3.02

Feb, 12, 2023

Feb, 3, 2023

Jan, 3, 2023

Dec, 29, 2022

SAVA

Cassava Sciences Inc

-13.96%

$29.88 - $25.71

Jan, 11, 2023

Dec, 12, 2022

Nov, 22, 2022